A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
NCT07730450
This study is recruiting at 5 US sites in 5 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to learn about the safety and effects of an updated COVID-19 vaccine (called BNT162b2) in adults 18 to 64 years of age. This study is seeking participants who: are medically stable have not had a recent COVID-19 infection have not had a recent vaccination do not have medical conditions that increase their risk of complications from COVID-19 All participants in this study will randomly receive 1 injection into their arm of either: BNT162b2 vaccine which targets COVID-19 and is selected for the 2026-2027 COVID-19 season, or Tdap vaccine which targets tetanus…
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- COVID-19 Vaccines
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 18 to 64 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- BioNTech SE
- Last updated on ClinicalTrials.gov
- August 7, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Diablo Clinical Research, LLC dba Flourish Research · Walnut Creek, CA
Florida · 1
- Palm Springs Community Health Center · Miami Lakes, FL
Hawaii · 1
- East-West Medical Research Institute · Honolulu, HI
North Carolina · 1
- Duke Vaccine and Trials Unit · Durham, NC
Utah · 1
- J. Lewis Research, Inc. / Foothill Family Clinic · Salt Lake City, UT
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.